The DOI matches its Crossref record; 234 of the 234 references it cites were found in a registry or an index.
Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone
Open accessAbstract
Calcium homeostasis is a tightly regulated process involving the co-ordinated efforts of the skeleton, kidney, parathyroid glands and intestine. Neoplasms can alter this homeostasis indirectly through the production of endocrine factors resulting in humoral hypercalcaemia of malignancy. Relatively common with breast and lung cancer, this paraneoplastic condition is most often due to tumour production of parathyroid hormone-related protein and ensuing increased osteoclastic bone resorption. Although control of hypercalcaemia is generally successful, the development of this complication is associated with a poor prognosis. The metastasis of tumour cells to bone represents another skeletal complication of malignancy. As explained in the ‘seed and soil’ hypothesis, bone represents a fertile ground for cancer cells to flourish. The molecular mechanisms of this mutually beneficial relationship between bone and cancer cells are beginning to be understood. In the case of osteolytic bone disease, tumour-produced parathyroid hormone-related protein stimulates osteoclasts that in turn secrete tumour-activating transforming growth factor-β that further stimulates local cancer cells. This ‘vicious cycle’ of bone metastases represents reciprocal bone/cancer cellular signals that likely modulate osteoblastic bone metastatic lesions as well. The development of targeted therapies to either block initial cancer cell chemotaxis, invasion and adhesion or to break the ‘vicious cycle’ is dependent on a more complete understanding of bone metastases. Although bisphosphonates delay progression of skeletal metastases, it is clear that more effective therapies are needed. Cancer-associated bone morbidity remains a major public health problem, and to improve therapy and prevention it is important to understand the pathophysiology of the effects of cancer on bone. This review will detail scientific advances regarding this area.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
(1909) · Journal of the American Medical Association · doi:10.1001/jama.1909.02550020033007 · Cited by 7,866
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Biochemical and Biophysical Research Communications
(1960) · Nature · doi:10.1038/186124d0 · Cited by 6,700
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
HOSKINS, R. G. (1953) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-13-4-473 · Cited by 3,780
Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid
Brown, E. M., Gamba, G., Riccardi, D., Lombardi, M., Butters, R., Kifor, O., Sun, A., Hediger, M. A., Lytton, J., & Hebert, S. C. (1993) · Nature · doi:10.1038/366575a0 · Cited by 2,643
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
Self-citationUp-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., & Dubois, R. N. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90246-1 · Cited by 2,514
Mechanism of activation of the TGF-β receptor
Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., & Massagué, J. (1994) · Nature · doi:10.1038/370341a0 · Cited by 2,337
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Molecular and cellular endocrinology
(1995) · Journal of Endocrinology · doi:10.1677/joe.0.147so19 · Cited by 1,991
Carter, H. E., Bhattacharyya, P. K., Weidman, K. R., & Fraenkel, G. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1981.tb06727.x · Cited by 1,896
Saad, F., Gleason, D. M., Murray, R., Tchekmedyian, S., Venner, P., Lacombe, L., Chin, J. L., Vinholes, J. J., Goas, J. A., & Chen, B. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.19.1458 · Cited by 1,656
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
URIST, M. R. (1967) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196709000-00023 · Cited by 1,590
Bertolini, D. R., Nedwin, G. E., Bringman, T. S., Smith, D. D., & Mundy, G. R. (1986) · Nature · doi:10.1038/319516a0 · Cited by 1,434
A Parathyroid Hormone-Related Protein Implicated in Malignant Hypercalcemia: Cloning and Expression
Suva, L. J., Winslow, G. A., Wettenhall, R. E. H., Hammonds, R. G., Moseley, J. M., Diefenbach-Jagger, H., Rodda, C. P., Kemp, B. E., Rodriguez, H., Chen, E. Y., et al. (1987) · Science · doi:10.1126/science.3616618 · Cited by 1,293
A G Protein-Linked Receptor for Parathyroid Hormone and Parathyroid Hormone-Related Peptide
Jüppner, H., Abou-Samra, A.-B., Freeman, M., Kong, X. F., Schipani, E., Richards, J., Kolakowski, L. F., Hock, J., Potts, J. T., Kronenberg, H. M., et al. (1991) · Science · doi:10.1126/science.1658941 · Cited by 1,249
Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.-I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.3.5837 · Cited by 1,201
Extracellular matrix remodelling: the role of matrix metalloproteinases
Stamenkovic, I. (2003) · The Journal of Pathology · doi:10.1002/path.1400 · Cited by 1,140
The clinical course of bone metastases from breast cancer
Coleman, R., & Rubens, R. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.13 · Cited by 1,084
Abou-Samra, A. B., Jüppner, H., Force, T., Freeman, M. W., Kong, X. F., Schipani, E., Urena, P., Richards, J., Bonventre, J. V., & Potts, J. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2732 · Cited by 1,005
Modulation of Osteoclast Differentiation
SUDA, T., TAKAHASHI, N., & MARTIN, T. J. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-66 · Cited by 1,004
Breast Cancer Research and Treatment
Alexander, M. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006151427889 · Cited by 997
Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone.
Taichman, R. S., Cooper, C. R., Keller, E. T., Pienta, K. J., Taichman, N. S., & McCauley, L. K. (2002) · PubMed · Cited by 994
Yin, J. J., Selander, K., Chirgwin, J. M., Dallas, M., Grubbs, B. G., Wieser, R., Massagué, J., Mundy, G. R., & Guise, T. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3523 · Cited by 986
Self-citationProstaglandins: Stimulation of Bone Resorption in Tissue Culture
KLEIN, D. C., & RAISZ, L. G. (1970) · Endocrinology · doi:10.1210/endo-86-6-1436 · Cited by 969
Src family kinases, key regulators of signal transduction
Parsons, S. J., & Parsons, J. T. (2004) · Oncogene · doi:10.1038/sj.onc.1208160 · Cited by 936
Cabot, R. C., Scully, R. E., Mark, E. J., McNeely, W. F., McNeely, B. U., Harris, W. H., & Rosenberg, A. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008233230808 · Cited by 896
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
Plotkin, L. I., Weinstein, R. S., Parfitt, A. M., Roberson, P. K., Manolagas, S. C., & Bellido, T. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6800 · Cited by 890 · cited 2×
“…multiple actions on osteoblasts such as (1) modulation of proliferation and differentiation (Reinholz et al. 2000), (2) prevention of apoptosis (Plotkin et al. 1999), (3) modulation of extracellular matrix protein production (Giuliani et al. 1998b, Klein et al. 1998), (4) regulation of the…”
BackgroundJournal of the American Society of Nephrology
Johnson, J. G. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480130164050 · Cited by 889
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY, BIOLOGY, PHYSICS
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.9.1382 · Cited by 877
Hauschka, P. V., Mavrakos, A. E., Iafrati, M. D., Doleman, S. E., & Klagsbrun, M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67143-1 · Cited by 869
Major, P., Lortholary, A., Hon, J., Abdi, E., Mills, G., Menssen, H. D., Yunus, F., Bell, R., Body, J., Quebe-Fehling, E., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.558 · Cited by 858
Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid.
Wood, J., Bonjean, K., Ruetz, S., Bellahcène, A., Devy, L., Foidart, J. M., Castronovo, V., & Green, J. R. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035295 · Cited by 854
Guise, T. A., Yin, J. J., Taylor, S. D., Kumagai, Y., Dallas, M., Boyce, B. F., Yoneda, T., & Mundy, G. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118947 · Cited by 851
Self-citationTong, D., Gillick, L., & Hendrickson, F. R. (1982) · Cancer · doi:10.1002/1097-0142(19820901)50:5<893::aid-cncr2820500515>3.0.co;2-y · Cited by 790
Bekker, P. J., Holloway, D. L., Rasmussen, A. S., Murphy, R., Martin, S. W., Leese, P. T., Holmes, G. B., Dunstan, C. R., & DePaoli, A. M. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040305 · Cited by 771
Mouridsen, H., Gershanovich, M., Sun, Y., Pérez-Carrión, R., Boni, C., Monnier, A., Apffelstaedt, J., Smith, R., Sleeboom, H. P., Jaenicke, F., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.194 · Cited by 746
Parathyroid hormone-related protein purified from a human lung cancer cell line.
Moseley, J. M., Kubota, M., Diefenbach-Jagger, H., Wettenhall, R. E., Kemp, B. E., Suva, L. J., Rodda, C. P., Ebeling, P. R., Hudson, P. J., & Zajac, J. D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.14.5048 · Cited by 734
TAKAHASHI, N., YAMANA, H., YOSHIKI, S., ROODMAN, G. D., MUNDY, G. R., JONES, S. J., BOYDE, A., & SUDA, T. (1988) · Endocrinology · doi:10.1210/endo-122-4-1373 · Cited by 730
Rosen, L. S., Gordon, D., Tchekmedyian, S., Yanagihara, R., Hirsh, V., Krzakowski, M., Pawlicki, M., de Souza, P., Zheng, M., Urbanowitz, G., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.105 · Cited by 729
NORMAN, A. W., ROTH, J., & ORCI, L. (1982) · Endocrine Reviews · doi:10.1210/edrv-3-4-331 · Cited by 703
Wieser, R., Wrana, J. L., & Massagué, J. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07214.x · Cited by 699
Diagnostic Evaluation of Low Back Pain with Emphasis on Imaging
Jarvik, J. G., & Deyo, R. A. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-7-200210010-00010 · Cited by 697
Cauley, J. A., Norton, L., Lippman, M. E., Eckert, S., Krueger, K. A., Purdie, D. W., Farrerons, J., Karasik, A., Mellstrom, D., Ng, K. W., et al. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1006478317173 · Cited by 678
Journal of Magnetic Resonance Imaging
(2006) · Journal of Magnetic Resonance Imaging · doi:10.1002/(issn)1522-2586 · Cited by 666
Lipton, A., Theriault, R. L., Hortobagyi, G. N., Simeone, J., Knight, R. D., Mellars, K., Reitsma, D. J., Heffernan, M., & Seaman, J. J. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000301)88:5<1082::aid-cncr20>3.0.co;2-z · Cited by 665
SMITH, M. R., EASTHAM, J., GLEASON, D. M., SHASHA, D., TCHEKMEDYIAN, S., & ZINNER, N. (2003) · Journal of Urology · doi:10.1097/01.ju.0000063820.94994.95 · Cited by 650
Helbig, G., Christopherson, K. W., Bhat-Nakshatri, P., Kumar, S., Kishimoto, H., Miller, K. D., Broxmeyer, H. E., & Nakshatri, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300609200 · Cited by 639
Wu, J. S.-Y., Wong, R., Johnston, M., Bezjak, A., & Whelan, T. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04147-0 · Cited by 601
Fleisch, H. (1991) · Drugs · doi:10.2165/00003495-199142060-00003 · Cited by 581
Integrin activation controls metastasis in human breast cancer
Felding-Habermann, B., O'Toole, T. E., Smith, J. W., Fransvea, E., Ruggeri, Z. M., Ginsberg, M. H., Hughes, P. E., Pampori, N., Shattil, S. J., Saven, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1853 · Cited by 577
Boissier, S., Ferreras, M., Peyruchaud, O., Magnetto, S., Ebetino, F. H., Colombel, M. C., Delmas, P. D., Delaissé, J., & Clézardin, P. (2000) · PubMed · Cited by 573
The endothelin axis: emerging role in cancer
Nelson, J., Bagnato, A., Battistini, B., & Nisen, P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc990 · Cited by 564
Fournier, P. G. J., Boissier, S., Filleur, S., Guglielmi, J., Cabon, F., Colombel, M. C., & Clézardin, P. (2002) · PubMed · Cited by 562
Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis.
Adams, J. S., Sharma, O. P., Gacad, M. A., & Singer, F. R. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111147 · Cited by 545
Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation1
Thomas, R. J., Guise, T. A., Yin, J. J., Elliott, J., Horwood, N. J., Martin, T. J., & Gillespie, M. T. (1999) · Endocrinology · doi:10.1210/endo.140.10.7037 · Cited by 536
Self-citationRegulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat.
Silver, J., Naveh-Many, T., Mayer, H., Schmelzer, H. J., & Popovtzer, M. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112714 · Cited by 536
Strewler, G. J., Stern, P. H., Jacobs, J. W., Eveloff, J., Klein, R. F., Leung, S. C., Rosenblatt, M., & Nissenson, R. A. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113275 · Cited by 533
Gene expression profiling predicts clinical outcome of breast cancer
(2002) · Nature · doi:10.1038/news020128-6 · Cited by 533
The interplay between Src and integrins in normal and tumor biology
Playford, M. P., & Schaller, M. D. (2004) · Oncogene · doi:10.1038/sj.onc.1208080 · Cited by 523
MOHAN, S., & BAYLINK, D. J. (1991) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199102000-00004 · Cited by 519
Calcitonin alters behaviour of isolated osteoclasts
Chambers, T. J., & Magnus, C. J. (1982) · The Journal of Pathology · doi:10.1002/path.1711360104 · Cited by 504
Molecular mechanisms of cancer pain
Mantyh, P. W., Clohisy, D. R., Koltzenburg, M., & Hunt, S. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc747 · Cited by 477
Yoneda, T., Williams, P. J., Hiraga, T., Niewolna, M., & Nishimura, R. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.8.1486 · Cited by 473
BMP and Ihh/PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation
Minina, E., Wenzel, H. M., Kreschel, C., Karp, S., Gaffield, W., McMahon, A. P., & Vortkamp, A. (2001) · Development · doi:10.1242/dev.128.22.4523 · Cited by 449
Pfeilschifter, J., & Mundy, G. R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.7.2024 · Cited by 431
Bisphosphonates induce apoptosis in human breast cancer cell lines
Senaratne, S. G., Pirianov, G., Mansi, J. L., Arnett, T. R., & Langrish, V (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1131 · Cited by 428
Barbour, G. L., Coburn, J. W., Slatopolsky, E., Norman, A. W., & Horst, R. L. (1981) · New England Journal of Medicine · doi:10.1056/nejm198108203050807 · Cited by 425
Bachelder, R. E., Wendt, M. A., & Mercurio, A. M. (2002) · PubMed · Cited by 424
Metabolism: Clinical and experimental
(1994) · Journal of the American Dietetic Association · doi:10.1016/0002-8223(94)92576-3 · Cited by 418
Proteolysis of Latent Transforming Growth Factor-β (TGF-β)-binding Protein-1 by Osteoclasts
Dallas, S. L., Rosser, J. L., Mundy, G. R., & Bonewald, L. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111663200 · Cited by 414
Geminder, H., Sagi-Assif, O., Goldberg, L., Meshel, T., Rechavi, G., Witz, I. P., & Ben-Baruch, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4747 · Cited by 409
Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo.
Lacey, D. L., Tan, H. L., Lu, J., Kaufman, S., Van, G., Qiu, W., Rattan, A., Scully, S., Fletcher, F., Juan, T., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64556-7 · Cited by 391
Powell, G. J., Southby, J., Danks, J. A., Stillwell, R. G., Hayman, J., Henderson, M. A., Bennett, R. C., & Martin, T. J. (1991) · PubMed · Cited by 390
Body, J.-J., Greipp, P., Coleman, R. E., Facon, T., Geurs, F., Fermand, J.-P., Harousseau, J.-L., Lipton, A., Mariette, X., Williams, C. D., et al. (2003) · Cancer · doi:10.1002/cncr.11138 · Cited by 383
A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases
Yin, J. J., Mohammad, K. S., Käkönen, S. M., Harris, S., Wu-Wong, J. R., Wessale, J. L., Padley, R. J., Garrett, I. R., Chirgwin, J. M., & Guise, T. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1830978100 · Cited by 381
Self-citationRandomized, Placebo-Controlled Trial of Clodronate in Patients With Primary Operable Breast Cancer
Powles, T., Paterson, S., Kanis, J. A., McCloskey, E., Ashley, S., Tidy, A., Rosenqvist, K., Smith, I., Ottestad, L., Legault, S., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.080 · Cited by 377
Carducci, M. A., Padley, R. J., Breul, J., Vogelzang, N. J., Zonnenberg, B. A., Daliani, D. D., Schulman, C. C., Nabulsi, A. A., Humerickhouse, R. A., Weinberg, M. A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.176 · Cited by 371
Reinholz, G. G., Getz, B., Pederson, L. G., Sanders, E. S., Subramaniam, M., Ingle, J. N., & Spelsberg, T. C. (2000) · PubMed · Cited by 366
Buzdar, A., Douma, J., Davidson, N., Elledge, R., Morgan, M., Smith, R., Porter, L., Nabholtz, J., Xiang, X., & Brady, C. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.14.3357 · Cited by 365
Effects of Interleukin-1 on Bone Turnover in Normal Mice*
BOYCE, B. F., AUFDEMORTE, T. B., GARRETT, I. R., YATES, A. J. P., & MUNDY, G. R. (1989) · Endocrinology · doi:10.1210/endo-125-3-1142 · Cited by 363
A murine model of experimental metastasis to bone and bone marrow.
Arguello, F., Baggs, R. B., & Frantz, C. N. (1988) · PubMed · Cited by 357
Similarity of Synthetic Peptide from Human Tumor to Parathyroid Hormone in Vivo and in Vitro
Horiuchi, N., Caulfield, M. P., Fisher, J. E., Goldman, M. E., McKee, R. L., Reagan, J. E., Levy, J. J., Nutt, R. F., Rodan, S. B., Schofield, T. L., et al. (1987) · Science · doi:10.1126/science.3685994 · Cited by 353
Kovacs, C. S., Lanske, B., Hunzelman, J. L., Guo, J., Karaplis, A. C., & Kronenberg, H. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15233 · Cited by 350
Skeletal Fractures Negatively Correlate With Overall Survival in Men With Prostate Cancer
Oefelein, M. G., Ricchiuti, V., Conrad, W., & Resnick, M. I. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64561-2 · Cited by 347
Boissier, S., Magnetto, S., Frappart, L., Cuzin, B., Ebetino, F. H., Delmas, P. D., & Clézardin, P. (1997) · PubMed · Cited by 343
Tamoxifen for Prevention of Breast Cancer
Cersosimo, R. J. (2003) · Annals of Pharmacotherapy · doi:10.1177/106002800303700219 · Cited by 343
Parathyroid hormone-dependent signaling pathways regulating genes in bone cells
Swarthout, J. T., D'Alonzo, R. C., Selvamurugan, N., & Partridge, N. C. (2002) · Gene · doi:10.1016/s0378-1119(01)00798-3 · Cited by 340
Quilty, P. M., Kirk, D., Bolger, J. J., Dearnaley, D. P., Lewington, V. J., Masone, M. D., Reed, N. S. E., Russell, J. M., & Yardley, J. (1994) · Radiotherapy and Oncology · doi:10.1016/0167-8140(94)90411-1 · Cited by 335
Rolli, M., Fransvea, E., Pilch, J., Saven, A., & Felding-Habermann, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633689100 · Cited by 332
Adrenomedullin Expression in Human Tumor Cell Lines ITS POTENTIAL ROLE AS AN AUTOCRINE GROWTH FACTOR
Jean Miller, M., Martínez, A., Unsworth, E. J., Thiele, C. J., Moody, T. W., Elsasser, T., & Cuttitta, F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23345 · Cited by 314
The IGF system and breast cancer.
Sachdev, D., & Yee, D. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080197 · Cited by 314
Na+/H+ exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling
Mahon, M. J., Donowitz, M., Yun, C. C., & Segre, G. V. (2002) · Nature · doi:10.1038/nature00816 · Cited by 313
The hypercalcemia of malignancy: Pathogenesis and management
Mundy, G. R., & Martin, T. J. (1982) · Metabolism · doi:10.1016/0026-0495(82)90012-9 · Cited by 311
Viereck, V., Emons, G., Lauck, V., Frosch, K.-H., Blaschke, S., Gründker, C., & Hofbauer, L. C. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6510 · Cited by 310
Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.
van der Pluijm, G., Vloedgraven, H., van Beek, E., van der Wee-Pals, L., Löwik, C., & Papapoulos, S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118841 · Cited by 305
Moallem, E., Kilav, R., Silver, J., & Naveh-Many, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.5253 · Cited by 303
GRILL, V., HO, P., BODY, J. J., JOHANSON, N., LEE, S. C., KUKREJA, S. C., MOSELEY, J. M., & MARTIN, T. J. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-6-1309 · Cited by 292
Wysolmerski, J. J., Philbrick, W. M., Dunbar, M. E., Lanske, B., Kronenberg, H., Karaplis, A., & Broadus, A. E. (1998) · Development · doi:10.1242/dev.125.7.1285 · Cited by 291
STEWART, A. F., VIGNERY, A., SILVERGLATE, A., RAVIN, N. D., LiVOLSI, V., BROADUS, A. E., & BARON, R. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-2-219 · Cited by 287
Acute Treatment of Hypercalcemia with Furosemide
Suki, W. N., Yium, J. J., Minden, M. V., Saller-Hebert, C., Eknoyan, G., & Martinez-Maldonado, M. (1970) · New England Journal of Medicine · doi:10.1056/nejm197010152831603 · Cited by 287
Parathyroid hormone-related protein is required for tooth eruption
Philbrick, W. M., Dreyer, B. E., Nakchbandi, I. A., & Karaplis, A. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11846 · Cited by 285
Decreased C-Src Expression Enhances Osteoblast Differentiation and Bone Formation
Marzia, M., Sims, N. A., Voit, S., Migliaccio, S., Taranta, A., Bernardini, S., Faraggiana, T., Yoneda, T., Mundy, G. R., Boyce, B. F., et al. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.2.311 · Cited by 284
Hypercalcemia Associated with Increased Serum Calcitriol Levels in Three Patients with Lymphoma
BRESLAU, N. A., McGUIRE, J. L., ZERWEKH, J. E., FRENKEL, E. P., & PAK, C. Y. C. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-1-1 · Cited by 272
VERBEEK, B. S., VROOM, T. M., ADRIAANSEN-SLOT, S. S., OTTENHOFF-KALFF, A. E., GEERTZEMA, J. G. N., HENNIPMAN, A., & RIJKSEN, G. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199612)180:4<383::aid-path686>3.0.co;2-n · Cited by 270
Giuliani, N., Pedrazzoni, M., Negri, G., Passeri, G., Impicciatore, M., & Girasole, G. (1998) · Bone · doi:10.1016/s8756-3282(98)00033-7 · Cited by 269
Portale, A. A., Halloran, B. P., & Morris, R. C. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114043 · Cited by 269
Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide.
Watanabe, H., TAKEHANA, K., Date, M., Shinozaki, T., & Raz, A. (1996) · PubMed · Cited by 268
Geoffroy, V., Kneissel, M., Fournier, B., Boyde, A., & Matthias, P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.17.6222-6233.2002 · Cited by 267
TGF-β signalling through the Smad pathway
Massaous, J., & Hata, A. (1997) · Trends in Cell Biology · doi:10.1016/s0962-8924(97)01036-2 · Cited by 265
Vitamin D Conversion by Sarcoid Lymph Node Homogenate
MASON, R. S., FRANKEL, T., CHAN, Y.-L., LISSNER, D., & POSEN, S. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-1-59 · Cited by 264
Reviews in Endocrine and Metabolic Disorders
Dorsch, T. R. (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2589 · Cited by 261
de la Mata, J., Uy, H. L., Guise, T. A., Story, B., Boyce, B. F., Mundy, G. R., & Roodman, G. D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117990 · Cited by 255
Self-citationScandinavian Journal of Rheumatology
Editor, G. H. (1992) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749209095065 · Cited by 254
Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer.
Southby, J., Kissin, M. W., Danks, J. A., Hayman, J., Moseley, J. M., Henderson, M. A., Bennett, R. C., & Martin, T. J. (1990) · PubMed · Cited by 249
Yoneda, T., Sasaki, A., Dunstan, C., Williams, P. J., Bauss, F., De Clerck, Y. A., & Mundy, G. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119435 · Cited by 247
Cancer as a cause of back pain: Frequency, clinical presentation, and diagnostic strategies
Deyo, R. A., & Diehl, A. K. (1988) · Journal of General Internal Medicine · doi:10.1007/bf02596337 · Cited by 245
Direct resorption of bone by human breast cancer cells in vitro
EILON, G., & MUNDY, G. R. (1978) · Nature · doi:10.1038/276726a0 · Cited by 235
Molecular Mechanisms of Tumor-Bone Interactions in Osteolytic Metastases
Chirgwin, J. M., & Guise, T. A. (2000) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v10.i2.50 · Cited by 233
Self-citationPlatelet and osteoclast β 3 integrins are critical for bone metastasis
Bakewell, S. J., Nestor, P., Prasad, S., Tomasson, M. H., Dowland, N., Mehrotra, M., Scarborough, R., Kanter, J., Abe, K., Phillips, D., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234372100 · Cited by 233
Role of endothelin-1 in osteoblastic bone metastases
Guise, T. A., Yin, J. J., & Mohammad, K. S. (2003) · Cancer · doi:10.1002/cncr.11129 · Cited by 228
Self-citationParathyroid hormone-related protein: Immunohistochemical localization in cancers and in normal skin
Danks, J. A., Ebeling, P. R., Hayman, J., Chou, S. T., Moseley, J. M., Dunlop, J., Kemp, B. E., & Martin, T. J. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040221 · Cited by 225
Clodronate decreases the frequency of skeletal metastases in women with breast cancer
Kanis, J. A., Powles, T., Paterson, A. H. G., McCloskey, E. V., & Ashley, S. (1996) · Bone · doi:10.1016/s8756-3282(96)00285-2 · Cited by 224
Bell, N. H. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111930 · Cited by 223
Hormonal Control of Calcium Homeostasis
Mundy, G. R., & Guise, T. A. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.8.1347 · Cited by 222
Self-citationInfusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal mice.
Sabatini, M., Boyce, B., Aufdemorte, T., Bonewald, L., & Mundy, G. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5235 · Cited by 216
Sanders, J. L., Chattopadhyay, N., Kifor, O., Yamaguchi, T., Butters, R. R., & Brown, E. M. (2000) · Endocrinology · doi:10.1210/en.141.12.4357 · Cited by 215
Bendre, M. S., Gaddy-Kurten, D., Mon-Foote, T., Akel, N. S., Skinner, R. A., Nicholas, R. W., & Suva, L. J. (2002) · PubMed · Cited by 212
Charhon, S. A., Chapuy, M. C., Delvin, E. E., Valentin-Opran, A., Edouard, C. M., & Meunier, P. J. (1983) · Cancer · doi:10.1002/1097-0142(19830301)51:5<918::aid-cncr2820510526>3.0.co;2-j · Cited by 208
Heshmati, H. M., Khosla, S., Robins, S. P., O'Fallon, W. M., Melton, L. J., & Riggs, B. L. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.1.172 · Cited by 207
Wieser, R., Attisano, L., Wrana, J. L., & Massagué, J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7239-7247.1993 · Cited by 206
Wysolmerski, J. J., Broadus, A. E., Zhou, J., Fuchs, E., Milstone, L. M., & Philbrick, W. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.3.1133 · Cited by 206
Coffman, J. A. (2003) · Cell Biology International · doi:10.1016/s1065-6995(03)00018-0 · Cited by 204
Black, K., Garrett, I. R., & Mundy, G. R. (1991) · Endocrinology · doi:10.1210/endo-128-5-2657 · Cited by 199
Effect of Calcitonin and Glucocorticoids in Combination on the Hypercalcemia of Malignancy
BINSTOCK, M. L., & MUNDY, G. R. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-2-269 · Cited by 199
Sabino, M. A. C., Ghilardi, J. R., Jongen, J. L. M., Keyser, C. P., Luger, N. M., Mach, D. B., Peters, C. M., Rogers, S. D., Schwei, M. J., Felipe, C. D., et al. (2002) · PubMed · Cited by 199
Mbalaviele, G., Dunstan, C. R., Sasaki, A., Williams, P. J., Mundy, G. R., & Yoneda, T. (1996) · PubMed · Cited by 195
Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor.
Nam, S. W., Clair, T., Kim, Y. S., McMarlin, A., Schiffmann, E., Liotta, L. A., & Stracke, M. L. (2001) · PubMed · Cited by 195
Powles, T. J., Clark, S. A., Easty, D. M., Easty, G. C., & Neville, A. M. (1973) · British Journal of Cancer · doi:10.1038/bjc.1973.154 · Cited by 195
Derenne, S., Amiot, M., Barillé, S., Collette, M., Robillard, N., Berthaud, P., Harousseau, J.-L., & Bataille, R. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.12.2048 · Cited by 195
Costa, L., Demers, L. M., Oliveira, A. G., Schaller, J. A., Costa, E. B., de Moura, M. C., & Lipton, A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.3.850 · Cited by 193
Safadi, F. F., Xu, J., Smock, S. L., Kanaan, R. A., Selim, A., Odgren, P. R., Marks, S. C., Owen, T. A., & Popoff, S. N. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10319 · Cited by 192
Cramer, S. D., Chen, Z., & Peehl, D. M. (1996) · Journal of Urology · doi:10.1016/s0022-5347(01)65919-6 · Cited by 192
Stromal factors involved in prostate carcinoma metastasis to bone
Cooper, C. R., Chay, C. H., Gendernalik, J. D., Lee, H.-L., Bhatia, J., Taichman, R. S., McCauley, L. K., Keller, E. T., & Pienta, K. J. (2003) · Cancer · doi:10.1002/cncr.11181 · Cited by 184
Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandins
GALASKO, C. S. B., & BENNETT, A. (1976) · Nature · doi:10.1038/263508a0 · Cited by 183
Parathyroid hormone-related protein and bone metastases
Guise, T. A. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1572::aid-cncr7>3.0.co;2-m · Cited by 180
Self-citationPurification of human tumor cell autocrine motility factor and molecular cloning of its receptor
Watanabe, H., Carmi, P., Hogan, V., Raz, T., Silletti, S., Nabi, I. R., & Raz, A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98859-9 · Cited by 178
Killian, C. S., Corral, D. A., Kawinski, E., & Constantine, R. I. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1506 · Cited by 178
Gupta, S., Adhami, V. M., Subbarayan, M., MacLennan, G. T., Lewin, J. S., Hafeli, U. O., Fu, P., & Mukhtar, H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2422 · Cited by 178
Nabholtz, J. M., Bonneterre, J., Buzdar, A., Robertson, J. F. R., & Thürlimann, B. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00326-5 · Cited by 176
Myoui, A., Nishimura, R., Williams, P. J., Hiraga, T., Tamura, D., Michigami, T., Mundy, G. R., & Yoneda, T. (2003) · PubMed · Cited by 174
Yi, B., Williams, P. J., Niewolna, M., Wang, Y., & Yoneda, T. (2002) · PubMed · Cited by 172
Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis
Mahmud, S., Franco, E., & Aprikian, A. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601416 · Cited by 171
Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer
Taube, T., Elomaa, I., Blomqvist, C., Beneton, M. N. C., & Kanis, J. A. (1994) · Bone · doi:10.1016/8756-3282(94)90703-x · Cited by 171
Comparative study of available medical therapy for hypercalcemia of malignancy
Mundy, G. R., Wilkinson, R., & Heath, D. A. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90961-0 · Cited by 163
Thiede, M. A., Daifotis, A. G., Weir, E. C., Brines, M. L., Burtis, W. J., Ikeda, K., Dreyer, B. E., Garfield, R. E., & Broadus, A. E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.6969 · Cited by 162
Zudaire, E., Martı́nez, A., & Cuttitta, F. (2003) · Regulatory Peptides · doi:10.1016/s0167-0115(03)00037-5 · Cited by 162
Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway.
Virtanen, S. S., Väänänen, H. K., Härkönen, P. L., & Lakkakorpi, P. T. (2002) · PubMed · Cited by 162
Parathyroid Hormone-Like Peptide in Normal and Neoplastic Human Endocrine Tissues*
ASA, S. L., HENDERSON, J., GOLTZMAN, D., & DRUCKER, D. J. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-5-1112 · Cited by 158
Thymosin β15: A novel regulator of tumor cell motility upregulated in metastatic prostate cancer
Bao, L., Loda, M. F., Janmey, P. A., Stewart, R., Anand‐Apte, B., & Zetter, B. R. (1996) · Nature Medicine · doi:10.1038/nm1296-1322 · Cited by 158
Brenza, H. L., & DeLuca, H. F. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1970 · Cited by 157
Johnson, R., Boyce, B. F., Mundy, G. R., & Roodman, G. D. (1989) · Endocrinology · doi:10.1210/endo-124-3-1424 · Cited by 152
Spuentrup, E., Buecker, A., Adam, G., van Vaals, J. J., & Günther, R. W. (2001) · American Journal of Roentgenology · doi:10.2214/ajr.176.2.1760351 · Cited by 152
Stimulation of Bone Resorption in Vitro by Synthetic Transforming Growth Factor-Alpha
Ibbotson, K. J., Twardzik, D. R., D'Souza, S. M., et al. (1985) · Science · doi:10.1126/science.3859011 · Cited by 151
Gucalp, R. A., Ritch, P. S., Wiernik, P. H., Sarma, P. R., Keller, A. M., Richman, S. P., Tauer, K. W., Neidhart, J. A., Mallette, L. E., & Siegel, R. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.1.134 · Cited by 150
Vargas, S. J., Gillespie, M. T., Powell, G. J., Southby, J., Danks, J. A., Moseley, J. M., & Martin, J. T. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070814 · Cited by 147
Jeffery, C. J., Bahnson, B. J., Chien, W. W., Ringe, D., & Petsko, G. A. (2000) · Biochemistry · doi:10.1021/bi991604m · Cited by 147
Sung, V., Stubbs, J. T., Fisher, L. W., Aaron, A. D., & Thompson, E. W. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199809)176:3<482::aid-jcp5>3.0.co;2-k · Cited by 146
Chemotactic responses of tumor cells to products of resorbing bone.
Orr, W., Varani, J., Gondek, M. D., Ward, P. A., & Mundy, G. R. (1979) · Science · doi:10.1126/science.569363 · Cited by 145
New therapeutics that antagonize endothelin: promises and frustrations
Remuzzi, G., Perico, N., & Benigni, A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd962 · Cited by 142
Chen, H.-L., Demiralp, B., Schneider, A., Koh, A. J., Silve, C., Wang, C. Y., & McCauley, L. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108913200 · Cited by 142
Calcitonin and the Formation of 32,52-AMP in Bone and Kidney*
Heersche, J. N. M., Marcus, R., & Aurbach, G. D. (1974) · Endocrinology · doi:10.1210/endo-94-1-241 · Cited by 129
Rehydration in the Treatment of Severe Hypercalcaemia
Hosking, D. J., Cowley, A. J., & BUCKNALL, C. A. (1981) · QJM · doi:10.1093/oxfordjournals.qjmed.a067700 · Cited by 128
Ranuncolo, S. M., Armanasco, E., Cresta, C., Joffé, E. B. D. K., & Puricelli, L. (2003) · International Journal of Cancer · doi:10.1002/ijc.11288 · Cited by 127
Wieser, R., Attisano, L., Wrana, J. L., & Massagué, J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7239 · Cited by 127
Bisphosphonates inhibit IL-6 production by human osteoblast-like cells
Giuliani, N. (1998) · Scandinavian Journal of Rheumatology · doi:10.1080/030097498441155 · Cited by 126
van der Pluijm, G., Sijmons, B., Vloedgraven, H. J., Deckers, M. M. L., Papapoulos, S. E., & Löwik, C. W. G. M. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.6.1077 · Cited by 124
Parathyroid hormone‐related protein in hypercalcaemia associated with haematological malignancy
Firkin, F. C., Seymour, J. F., Watson, A., et al. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.d01-1819.x · Cited by 118
MMP-2 Protein in Invasive Breast Cancer and the Impact of MMP-2/TIMP-2 Phenotype on Overall Survival
Nakopoulou, L., Tsirmpa, I., Alexandrou, P. T., Louvrou, A., Ampela, C., Markaki, S. P., & Davaris, P. S. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1021371028777 · Cited by 117
Mechanisms of Bisphosphonate Effects on Osteoclasts, Tumor Cell Growth, and Metastasis
Green, J. R., & Clézardin, P. (2002) · American Journal of Clinical Oncology · doi:10.1097/00000421-200212001-00002 · Cited by 116
The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast
Black, M. H., & Diamandis, E. P. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006380306781 · Cited by 116
Heidenreich, A., Hofmann, R. W., & Engelmann, U. H. (2001) · The Journal of Urology · doi:10.1097/00005392-200101000-00033 · Cited by 114
Interleukins in the Control of Osteoclast Differentiation
Martin, T. J., Romas, E., & Gillespie, M. T. (1998) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v8.i2.10 · Cited by 109
Tatsumi, S., Segawa, H., Morita, K., Haga, H., Kouda, T., Yamamoto, H., Inoue, Y., Nii, T., Katai, K., Taketani, Y., et al. (1998) · Endocrinology · doi:10.1210/endo.139.4.5925 · Cited by 109
Alpha v integrin inhibitors and cancer therapy.
Tucker, G. C. (2003) · PubMed · Cited by 108
Bekker, P. J., Holloway, D. L., Rasmussen, A. S., Murphy, R., Martin, S. W., Leese, P. T., Holmes, G. B., Dunstan, C. R., & DePaoli, A. M. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2005.20.12.2274 · Cited by 108
Tumour invasion: effects of cell adhesion and motility
VANROY, F., & Mareel, M. (1992) · Trends in Cell Biology · doi:10.1016/0962-8924(92)90035-l · Cited by 106
Nakai, M., Mundy, G. R., Williams, P. J., et al. (1992) · PubMed · Cited by 105
Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity.
Bachmeier, B. E., Nerlich, M. L., Lichtinghagen, R., & Sommerhoff, C. P. (2001) · PubMed · Cited by 99
Grill, V., & Martin, T. J. (2000) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1026597816193 · Cited by 99
Metabolic Acidosis Suppresses 25-Hydroxyvitamin D3-1α-Hydroxylase in the Rat Kidney
Kawashima, H., Kraut, J. A., & Kurokawa, K. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110586 · Cited by 97
Iguchi, H., Tanaka, S., Ozawa, Y., Kashiwakuma, T., Kimura, T., Hiraga, T., Ozawa, H., & Kono, A. (1996) · PubMed · Cited by 97
Cellular and molecular basis of preferential metastasis of breast cancer to bone
Yoneda, T. (2000) · Journal of Orthopaedic Science · doi:10.1007/s007760050012 · Cited by 93
Cited by
Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer Metastasis
Langley, R. R., & Fidler, I. J. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0027 · Cited by 373
Transmigration: A New Property of Mature Multinucleated Osteoclasts
Saltel, F., Chabadel, A., Zhao, Y., Lafage-Proust, M.-H., Clézardin, P., Jurdic, P., & Bonnelye, E. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060821 · Cited by 41
Metadata
- Authors
- Clines, G. A., & Guise, T. A.
- Venue
- Endocrine-Related Cancer
- Publisher
- Bioscientifica
- Published
- 2005-09
- Volume
- 12
- Issue
- 3
- Pages
- 549-583
- ISSN
- 1351-0088 (ISSN-L)
- 1479-6821
- OpenAlex
- W2154028327
- Cited by
- 253
- References
- 234
- FWCI
- 7.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.